Literature DB >> 27297947

Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.

Samih H Nasr1, Surendra Dasari2, Linda Hasadsri1, Jason D Theis1, Julie A Vrana1, Morie A Gertz3, Prasuna Muppa1, Michael T Zimmermann2, Karen L Grogg1, Angela Dispenzieri1,3, Sanjeev Sethi1, W Edward Highsmith1, Giampaolo Merlini4, Nelson Leung3, Paul J Kurtin5.   

Abstract

Amyloidosis is characterized by extracellular deposition of misfolded proteins as insoluble fibrils. Most renal amyloidosis cases are Ig light chain, AA, or leukocyte chemotactic factor 2 amyloidosis, but rare hereditary forms can also involve the kidneys. Here, we describe the case of a 61-year-old woman who presented with nephrotic syndrome and renal impairment. Examination of the renal biopsy specimen revealed amyloidosis with predominant involvement of glomeruli and medullary interstitium. Proteomic analysis of Congo red-positive deposits detected large amounts of the Apo-CII protein. DNA sequencing of the APOC2 gene in the patient and one of her children detected a heterozygous c.206A→T transition, causing an E69V missense mutation. We also detected the mutant peptide in the proband's renal amyloid deposits. Using proteomics, we identified seven additional elderly patients with Apo-CII-rich amyloid deposits, all of whom had kidney involvement and histologically exhibited nodular glomerular involvement. Although prior in vitro studies have shown that Apo-CII can form amyloid fibrils and that certain mutations in this protein promote amyloid fibrillogenesis, there are no reports of this type of amyloidosis in humans. We propose that this study reveals a new form of hereditary amyloidosis (AApoCII) that is derived from the Apo-CII protein and appears to manifest in the elderly and preferentially affect the kidneys.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  amyloidosis; apolipoprotein C-II; hereditary amyloidosis; renal amyloid

Mesh:

Substances:

Year:  2016        PMID: 27297947      PMCID: PMC5280007          DOI: 10.1681/ASN.2015111228

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

1.  Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils.

Authors:  Timothy M Ryan; Chai L Teoh; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2010-04-28       Impact factor: 5.469

Review 2.  Effects of mutation on the amyloidogenic propensity of apolipoprotein C-II(60-70) peptide.

Authors:  Nevena Todorova; Andrew Hung; Simon M Maaser; Michael D W Griffin; John Karas; Geoffrey J Howlett; Irene Yarovsky
Journal:  Phys Chem Chem Phys       Date:  2010-10-11       Impact factor: 3.676

3.  Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis.

Authors:  Jason D Theis; Surendra Dasari; Julie A Vrana; Paul J Kurtin; Ahmet Dogan
Journal:  J Mass Spectrom       Date:  2013-10       Impact factor: 1.982

4.  Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses.

Authors:  Surendra Dasari; Jason D Theis; Julie A Vrana; Roman M Zenka; Michael T Zimmermann; Jean-Pierre A Kocher; W Edward Highsmith; Paul J Kurtin; Ahmet Dogan
Journal:  J Proteome Res       Date:  2014-04-03       Impact factor: 4.466

5.  Medullary amyloidosis associated with apolipoprotein A-IV deposition.

Authors:  Sanjeev Sethi; Jason D Theis; Shirley M Shiller; Cynthia C Nast; David Harrison; Helmut G Rennke; Julie A Vrana; Ahmet Dogan
Journal:  Kidney Int       Date:  2011-09-07       Impact factor: 10.612

6.  Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops.

Authors:  D M Hatters; C E MacPhee; L J Lawrence; W H Sawyer; G J Howlett
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

7.  A structural model for apolipoprotein C-II amyloid fibrils: experimental characterization and molecular dynamics simulations.

Authors:  Chai Lean Teoh; Chi L L Pham; Nevena Todorova; Andrew Hung; Craig N Lincoln; Emma Lees; Yuen Han Lam; Katrina J Binger; Neil H Thomson; Sheena E Radford; Trevor A Smith; Shirley A Müller; Andreas Engel; Michael D W Griffin; Irene Yarovsky; Paul R Gooley; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2010-12-10       Impact factor: 5.469

8.  The structure and interactions of human apolipoprotein C-II in dodecyl phosphocholine.

Authors:  Christopher A MacRaild; Geoffrey J Howlett; Paul R Gooley
Journal:  Biochemistry       Date:  2004-06-29       Impact factor: 3.162

9.  Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.

Authors:  G Baggio; E Manzato; C Gabelli; R Fellin; S Martini; G B Enzi; F Verlato; M R Baiocchi; D L Sprecher; M L Kashyap
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

10.  Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.

Authors:  W C Breckenridge; J A Little; G Steiner; A Chow; M Poapst
Journal:  N Engl J Med       Date:  1978-06-08       Impact factor: 91.245

View more
  19 in total

Review 1.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

2.  Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype.

Authors:  Samih H Nasr; Surendra Dasari; John R Mills; Jason D Theis; Michael T Zimmermann; Rafael Fonseca; Julie A Vrana; Steven J Lester; Brooke M McLaughlin; Robert Gillespie; W Edward Highsmith; John J Lee; Angela Dispenzieri; Paul J Kurtin
Journal:  J Am Soc Nephrol       Date:  2017-01-03       Impact factor: 10.121

Review 3.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

Review 4.  Fibrinogen alpha amyloidosis: insights from proteomics.

Authors:  Jessica Chapman; Ahmet Dogan
Journal:  Expert Rev Proteomics       Date:  2019-08-28       Impact factor: 3.940

Review 5.  Pathology and diagnosis of renal non-AL amyloidosis.

Authors:  Sanjeev Sethi; Jason D Theis
Journal:  J Nephrol       Date:  2017-08-21       Impact factor: 3.902

6.  Triglyceride increase in the core of high-density lipoproteins augments apolipoprotein dissociation from the surface: Potential implications for treatment of apolipoprotein deposition diseases.

Authors:  Shobini Jayaraman; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-18       Impact factor: 5.187

Review 7.  Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji
Journal:  Glycoconj J       Date:  2018-07-12       Impact factor: 2.916

8.  N- and C-terminal regions of αB-crystallin and Hsp27 mediate inhibition of amyloid nucleation, fibril binding, and fibril disaggregation.

Authors:  Emily E Selig; Courtney O Zlatic; Dezerae Cox; Yee-Foong Mok; Paul R Gooley; Heath Ecroyd; Michael D W Griffin
Journal:  J Biol Chem       Date:  2020-05-16       Impact factor: 5.157

9.  The Clinical Impact of Proteomics in Amyloid Typing.

Authors:  Michelle M Hill; Surendra Dasari; Peter Mollee; Giampaolo Merlini; Catherine E Costello; Bouke P C Hazenberg; Martha Grogan; Angela Dispenzieri; Morie A Gertz; Taxiarchis Kourelis; Ellen D McPhail
Journal:  Mayo Clin Proc       Date:  2021-04-09       Impact factor: 11.104

10.  DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis.

Authors:  Samih H Nasr; Julie A Vrana; Surendra Dasari; Frank Bridoux; Mary E Fidler; Sihem Kaaki; Nathalie Quellard; Alexia Rinsant; Jean Michel Goujon; Sanjeev Sethi; Fernando C Fervenza; Lynn D Cornell; Samar M Said; Ellen D McPhail; Loren P Herrera Hernandez; Joseph P Grande; Marie C Hogan; John C Lieske; Nelson Leung; Paul J Kurtin; Mariam P Alexander
Journal:  Kidney Int Rep       Date:  2017-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.